Christian Shleider Carnero Canales is an expert in Infectiology at São Paulo State University (Brazil). Christian Shleider Carnero Canales has authored 18 publications, the most recent in 2026. SLR score: 73 (community average: 125). How the SLR is computed.

LeadR Profile

Christian Shleider Carnero Canales São Paulo State University Brazil
73 ScienceLeadR Reputation 73
Network Map

Infectiology

Subspecialties: Biochemistry - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2026 - 2026

Source: PubMed

Universidad Autónoma del Perú

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 18

Citations

Citations: 86 1st author: 7 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Peptide-Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives.
PMID 42750372 — cell-penetrating peptides, cells, malaria, pharmaceutical preparations, chemistry, pharmaceutical, parasites, leishmaniasis
ChemMedChem20260
Comparative Biological and Functional Profiling of Single-Position Cysteine Substitutions in the HNP-1-Derived Peptide Pep-H Against Mycobacterium tuberculosis.
PMID 42353741 — cysteine, mycobacterium, ethidium, tuberculosis, hemolysis, mycobacterium tuberculosis
Antibiotics (Basel)20261
Dual-Peptide Nanoplatform: Mesoporous Silica Nanoparticles Functionalized With a Cell-Penetrating Peptide and Loaded With Rationally Designed Antimicrobial Peptides for Tuberculosis Therapy.
PMID 41906540 — cell-penetrating peptides, cells, nanoparticles, macrophages, tuberculosis, fibroblasts, therapeutics, mycobacterium tuberculosis
Adv Healthc Mater20260
Selective Copper(II) Complexes against Mycobacterium tuberculosis.
PMID 41552513 — mycobacterium, tuberculosis, diamines, mycobacterium tuberculosis
ACS Omega20250
Redefining Therapies for Drug-Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design.
PMID 41549858 — drug discovery, pharmaceutical preparations, tuberculosis, drug delivery systems, therapeutics, nanotechnology
Adv Healthc Mater20260

LeadR Networks

Main global connection map